Results 31 to 40 of about 4,127 (170)

Contrast-enhanced ultrasound identifies early extrahepatic collateral contributing to residual hepatocellular tumor viability after transarterial chemoembolization

open access: yesRadiology Case Reports, 2018
The mainstay of treatment for unresectable hepatocellular carcinoma is locoregional therapy including percutaneous ablation and transarterial chemo- and radioembolization.
Sriharsha Gummadi, MD   +5 more
doaj   +1 more source

Metastatic breast cancer from a hepatocellular carcinoma: a case report [PDF]

open access: yesKorean Journal of Clinical Oncology, 2022
Breast metastases from extramammary malignancies are rare. Here, we report a case of breast metastasis from hepatocellular carcinoma (HCC) after breast mass excision in a 63-year-old woman.
Hyewon Bang   +6 more
doaj   +1 more source

Dose finding study for unilobar radioembolization using holmium-166 microspheres to improve resectability in patients with HCC: the RALLY protocol

open access: yesBMC Cancer, 2023
Background High dose unilobar radioembolization (also termed ‘radiation lobectomy’)—the transarterial unilobar infusion of radioactive microspheres as a means of controlling tumour growth while concomitantly inducing future liver remnant hypertrophy—has ...
Daan Andel   +19 more
doaj   +1 more source

Transarterial radioembolization for hepatocellular carcinoma: An update and perspectives

open access: yesWorld Journal of Gastroenterology, 2015
In the last decade trans-arterial radioembolization has given promising results in the treatment of patients with intermediate or advanced stage hepatocellular carcinoma (HCC), both in terms of disease control and tolerability profile. This technique consists of the selective intra-arterial administration of microspheres loaded with a radioactive ...
Sacco, Rodolfo   +16 more
openaire   +3 more sources

How to Prepare a Patient for Transarterial Radioembolization? A Practical Guide [PDF]

open access: yesCardioVascular and Interventional Radiology, 2015
Transarterial radioembolization consist in delivering small particles loaded with Yttrium90, a pure beta emitter, in order to treat primary and secondary liver tumors. This treatment needs precaution since inadequate delivery of these beads can lead to severe complications.
Denys A   +6 more
openaire   +3 more sources

Celiac Artery Stenting to Facilitate Hepatic Yttrium-90 Radioembolization Therapy

open access: yesCase Reports in Radiology, 2012
Radioembolization offers a novel way to treat the nonresectable, liver predominant hepatic malignancies with better tumor response and overall progression-free survival rates.
Murthy R. Chamarthy   +5 more
doaj   +1 more source

Transarterial therapy: An evolving treatment modality of hepatocellular carcinoma

open access: yesThe Saudi Journal of Gastroenterology, 2014
Liver cancer is the fifth most common cancer in men, the seventh most common in women, and the third most common cause of death from cancer worldwide.
Khalid A Jazieh   +2 more
doaj   +1 more source

An Evidence-Based Multidisciplinary Approach to the Management of Hepatocellular Carcinoma (HCC): The Alberta HCC Algorithm

open access: yesCanadian Journal of Gastroenterology, 2010
Hepatocellular carcinoma (HCC) is one of only a few malignancies with an increasing incidence in North America. Because the vast majority of HCCs occur in the setting of a cirrhotic liver, management of this malignancy is best performed in a ...
Kelly W Burak, Norman M Kneteman
doaj   +1 more source

Paediatric development of radiopharmaceutical imaging agents and radioligand therapeutics

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract This review focuses on the development of radiopharmaceutical imaging agents and radioligand therapeutics for paediatric use. Nuclear medicine plays an important role in the diagnosis and treatment of various childhood conditions, including cancers, infections and brain disorders.
Justin L. Hay   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy